Lei Liu
- Molecular Biology top 1%
- Circular RNAs in diseases 17
- Genomics and Phylogenetic Studies 13
- Extracellular vesicles in disease 13
- Immunology top 2%
- Infectious Diseases top 1%
- Cancer Research top 2%
- MicroRNA in disease regulation 24
- Cancer-related molecular mechanisms research 11
- Neurology top 2%
-
- Alzheimer's disease research and treatments 28
-
- Plant Molecular Biology Research 18
-
- Neuroscience and Neuropharmacology Research 13
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lei Liu
341 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Molecular Biology 5.4k
- Immunology 1.5k
- Infectious Diseases 1.2k
- Cancer Research 996
- Neurology 750
Countries citing papers authored by Lei Liu
This map shows the geographic impact of Lei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Liu more than expected).
Fields of papers citing papers by Lei Liu
This network shows the impact of papers produced by Lei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Liu. The network helps show where Lei Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 46 | |
| 14 | 2024 | 52 | |
| 15 | 2024 | 18 | |
| 16 | 2023 | 5 | |
| 17 | 2023 | 0 | |
| 18 | 2023 | 2 | |
| 19 | 2017 | 195 | |
| 20 | [Genetic factors in the occurrence of neonatal unconjugated hyperbilirubinemia]. | 2012 | 0 |
About Lei Liu
Lei Liu is a scholar working on Cancer Research, Molecular Biology and Physiology, having authored 374 papers that have together received 10.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (28 papers), MicroRNA in disease regulation (24 papers), Plant Molecular Biology Research (18 papers), Circular RNAs in diseases (17 papers), Neuroscience and Neuropharmacology Research (13 papers), Genomics and Phylogenetic Studies (13 papers), Extracellular vesicles in disease (13 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Molecular Biology (5.4k citations), Immunology (1.5k citations) and Infectious Diseases (1.2k citations). Lei Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Huayi Wang, Xiaodong Wang, Lijing Su, Josep Rizo, Lifeng Wang, Liming Sun, Fu‐Sheng Wang, Zheng Zhang, Jing Yuan and Ido Amit.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.